R2 Technology to sell ImageChecker in Japan

Article

Mammography computer-aided detection firm R2 Technology’s ImageChecker CAD unit has received approval from the Japanese Ministry of Health and Welfare for use in breast cancer screening in Japan. The unit will be distributed by R2’s partner,

Mammography computer-aided detection firm R2 Technology’s ImageChecker CAD unit has received approval from the Japanese Ministry of Health and Welfare for use in breast cancer screening in Japan. The unit will be distributed by R2’s partner, Marubeni America, with which R2 signed an agreement last spring (SCAN 6/23/99).

The MHW’s decision came as more good news for the Los Altos, CA, company, which is seeing its efforts to establish industry alliances pay off. In 1998, R2 signed an exclusive OEM supply deal with GE Medical Systems of Milwaukee. GE agreed to bundle ImageChecker with the full-field digital mammography system it had under development (SCAN 4/29/98). With the Food and Drug Administration’s Jan. 31 approval of GE’s Senographe (see story, page 5), R2 comes closer to bringing a digital version of ImageChecker to market.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.